Literature DB >> 20981766

Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders.

Brieana M Rowles1, Robert L Findling.   

Abstract

Developmental disorders such as subaverage intelligence, pervasive developmental disorders, and genetic syndromes are frequently associated with comorbid attention-deficit/hyperactivity disorder (ADHD) or ADHD-like symptoms. While there are not pharmacological cures for these developmental disorders, coinciding ADHD and ADHD-like symptoms that contribute to difficulties in psychosocial functioning are frequently able to be addressed by pharmacotherapy. This article reviews what is known about the efficacy and tolerability of pharmacological interventions for the treatment of children and adolescents suffering from developmental disorders and comorbid ADHD/ADHD-like symptoms.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20981766     DOI： 10.1002/ddrr.120

Source DB:  PubMed          Journal:  Dev Disabil Res Rev        ISSN： 1940-5529


  9 in total

Review 1.  Early pathogenic care and the development of ADHD-like symptoms.

Authors:  Brigitte Dahmen; Vanessa Pütz; Beate Herpertz-Dahlmann; Kerstin Konrad
Journal:  J Neural Transm (Vienna)       Date:  2012-06-02       Impact factor: 3.575

2.  Prenatal alcohol exposure and sleep-wake behaviors: exploratory and naturalistic observations in the clinical setting and in an animal model.

Authors:  Osman S Ipsiroglu; Katarina Wind; Yi-Hsuan Amy Hung; Mai Berger; Forson Chan; Wayne Yu; Sylvia Stockler; Joanne Weinberg
Journal:  Sleep Med       Date:  2018-10-25       Impact factor: 3.492

3.  Effects of psychotropic drugs on second messenger signaling and preference for nicotine in juvenile male mice.

Authors:  Lyonna F Alcantara; Brandon L Warren; Eric M Parise; Sergio D Iñiguez; Carlos A Bolaños-Guzmán
Journal:  Psychopharmacology (Berl)       Date:  2014-01-23       Impact factor: 4.530

4.  Ningdong granule: a complementary and alternative therapy in the treatment of attention deficit/hyperactivity disorder.

Authors:  Ji-Jun Li; Zai-Wang Li; Shu-Zhen Wang; Fang-Hua Qi; Lin Zhao; Hong Lv; An-Yuan Li
Journal:  Psychopharmacology (Berl)       Date:  2011-03-18       Impact factor: 4.530

5.  Altered serotonergic function may partially account for behavioral endophenotypes in steroid sulfatase-deficient mice.

Authors:  Simon Trent; Tommaso Cassano; Gaurav Bedse; Obah A Ojarikre; Trevor Humby; William Davies
Journal:  Neuropsychopharmacology       Date:  2011-12-21       Impact factor: 7.853

6.  Traditional Oriental Herbal Medicine for Children and Adolescents with ADHD: A Systematic Review.

Authors:  Yuk Wo Wong; Deog-Gon Kim; Jin-Yong Lee
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-17       Impact factor: 2.629

7.  Do parents of children with attention-deficit/hyperactivity disorder (ADHD) receive adequate information about the disorder and its treatments? A qualitative investigation.

Authors:  Rana Ahmed; Jacqueline M Borst; Cheng Wei Yong; Parisa Aslani
Journal:  Patient Prefer Adherence       Date:  2014-05-08       Impact factor: 2.711

Review 8.  Natural Product-Derived Treatments for Attention-Deficit/Hyperactivity Disorder: Safety, Efficacy, and Therapeutic Potential of Combination Therapy.

Authors:  James Ahn; Hyung Seok Ahn; Jae Hoon Cheong; Ike Dela Peña
Journal:  Neural Plast       Date:  2016-02-04       Impact factor: 3.599

9.  The NKCC1 antagonist bumetanide mitigates interneuronopathy associated with ethanol exposure in utero.

Authors:  Alexander Gj Skorput; Stephanie M Lee; Pamela Wl Yeh; Hermes H Yeh
Journal:  Elife       Date:  2019-09-23       Impact factor: 8.140
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.